KOSDAQCosmetics027050

Coreana Cosmetics

₩1,272▲ 1.52%2026-11-18 close
Market Cap
₩50.9B
Turnover
₩64,588,432
Volume
50K
Shares out.
40M
PER
—
PBR
0.5×
EPS
-₩246
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Coreana: Shrinking Sales and Five Straight Quarters of Operating Losses

Coreana Cosmetics swung to an annual operating loss of KRW 4.39 billion in 2025, has posted operating losses in each of the last five reported quarters, and has seen sales decline in 2024 and 2025 after peaking in 2023.

  1. 1

    The company posted a 2025 operating loss of KRW 4.39 billion and a net loss attributable to controlling shareholders of KRW 7.74 billion, with the operating margin at -6.0%.

  2. 2

    Third-quarter 2026 sales were KRW 16 billion, down 4.9% year on year, and the operating loss of KRW 1.16 billion was narrower than a year earlier.

  3. 3

    Net income attributable to controlling shareholders turned positive at KRW 215 million in the first quarter of 2026, but net losses returned in the second and third quarters.

  4. 4

    The debt-to-equity ratio was 18.2% at the end of 2025 with total equity of KRW 83.7 billion, yet operating cash flow turned negative at KRW -1.55 billion in 2025.

  5. 5

    Abroad, the company listed its dermatology-focused skincare brand at the CJ Olive Young Pasadena store in the United States and says it will add more North American locations.

02

Business structure

Coreana Cosmetics was founded on November 15, 1988 and started as a direct-sales cosmetics company, with direct and door-to-door sales once accounting for close to 80% of revenue. The company has since diversified into retail, home shopping, exports, OEM and ODM, and skin-care shops.

Basic skincare is the core category: basic-care sales were KRW 39 billion in the first nine months of 2025, down 22% year on year. Color cosmetics fell 47% to KRW 2.2 billion over the same period, while other cosmetics rose 88% to KRW 14.6 billion, lifting their share to 26%.

By region, Korea accounted for KRW 42.4 billion or 75% of nine-month 2025 sales, Asia for KRW 13.6 billion or 24%, and the Americas were nearly negligible. Its China subsidiary Coreana Cosmetics Tianjin posted nine-month 2025 sales of KRW 8.6 billion, down 33%.

The brand portfolio spans anti-aging, an esthetic franchise, and a dermatology skincare line.

Competition overlaps with domestic direct-sales brands and indie brands that grew through CJ Olive Young and other health-and-beauty channels, and the business model differs from large ODM players such as Cosmax and Kolmar Korea.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩16.8B-₩1.6B−9.3%
2025Q4₩17.3B-₩1.4B−8.1%
2026Q1₩18.6B-₩500M−2.5%
2026Q2₩18.9B-₩1.1B−5.6%
2026Q3₩16B-₩1.2B−7.3%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩80.4B₩900M₩1.5B1.1%1.8%27.5%
2023₩86B₩900M₩1.8B1.1%2.1%31.1%
2024₩82.5B₩400M₩800M0.5%0.9%24.9%
2025₩73.7B-₩4.4B-₩7.7B−6.0%−9.2%18.2%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-18

04

Earnings analysis

Revenue on a disclosed basis rose from KRW 80.4 billion in 2022 to KRW 86 billion in 2023, a 7.0% increase that marked the peak, then fell 4.2% to KRW 82.5 billion in 2024 and 10.6% to KRW 73.7 billion in 2025. The largest year in 2022 to 2025 was 2023 and the smallest was 2025.

Operating profit went from KRW 876 million in 2022 and KRW 936 million in 2023 (up 6.8%) to KRW 441 million in 2024 (down 52.9%), then turned into an operating loss of KRW 4.39 billion in 2025. The operating margin slid from 1.1% in 2022 and 1.1% in 2023 to 0.5% in 2024 and -6.0% in 2025.

Net income attributable to controlling shareholders peaked at KRW 1.79 billion in 2023, fell to KRW 822 million in 2024 (down 54.1%), and became a loss of KRW 7.74 billion in 2025. Net loss including non-controlling interests was KRW 7.75 billion in 2025, nearly the same as the controlling-shareholder figure.

The company attributes the decline to a structurally higher raw-material cost burden, a prolonged slowdown in China and weaker K-beauty competitiveness that stalled exports, and shrinking in-person distribution that compounded lower sales.

Taken at face value, the losses look rooted in cost, export and channel structure rather than one-off items. Operating cash flow fell from KRW 5.6 billion in 2022 to KRW -1.55 billion in 2025.

Quarterly sales rose from KRW 16.8 billion in the third quarter of 2025 to KRW 17.3 billion in the fourth quarter, KRW 18.6 billion in the first quarter of 2026 and KRW 18.9 billion in the second quarter, before falling 15.5% to KRW 16 billion in the third quarter of 2026.

Operating losses narrowed from KRW 1.56 billion in the third quarter of 2025 and KRW 1.39 billion in the fourth quarter to KRW 465 million in the first quarter of 2026, then widened to KRW 1.06 billion in the second quarter and KRW 1.16 billion in the third quarter of 2026.

Net income attributable to controlling shareholders turned positive at KRW 215 million in the first quarter of 2026, then posted losses of KRW 1.14 billion and KRW 1.41 billion in the second and third quarters, two straight loss quarters.

The sum of controlling-shareholder net losses over the last four quarters is KRW 7.78 billion. Preliminary figures show nine-month 2026 sales of KRW 53.5 billion, down 5.1% year on year.

05

Industry analysis

The cosmetics sector is in an export-led expansion. Cosmetics exports rose 31.1% year on year in the first three quarters of 2026 to USD 11.1 billion, a record. K-beauty exports also passed the full-year 2025 total by October 2026.

Growth is concentrated in global brands and large ODM makers: APR and d'Alba Global posted strong results, and Cosmax and Kolmar Korea reported record third-quarter profits. Cosmecca Korea, by contrast, saw third-quarter net income fall 53.5% as its US unit shrank.

Against that backdrop, Coreana's reliance on direct sales and domestic offline retail limits its share of the export boom. In color cosmetics, indie brands that grew through H&B stores and e-commerce gained ground, while Coreana's color sales fell 47% in the first nine months of 2025.

Analysts have criticized the company for slow responses to shifting trends and heavy dependence on traditional distribution. The decline at its Tianjin subsidiary shows that the China slowdown is hitting Coreana directly.

In cycle terms, the sector is in an export expansion phase, while Coreana is in a restructuring phase where raw-material costs and channel transition overlap.

06

Outlook

In June 2026, the company said it had placed its dermatology skincare brand at the CJ Olive Young Pasadena store in the United States. It plans to use the store as a base for introducing its products to local consumers, and to keep adding key North American locations in line with Olive Young's global expansion.

Management maintains that earnings can recover once the transition from direct sales to an online structure stabilizes. Analysts counter that the US entry came late relative to competitors that already hold the North American market.

They also argue that an overseas turnaround is hard to expect in the short term if the current structure persists. No numeric full-year guidance was presented in the material reviewed. The next periodic report is the 2026 annual report, which will fix the full-year 2026 operating margin and operating loss.

Based on the 2025 timing, preliminary 2026 full-year results are likely around February 2027. The points to watch are whether quarterly sales recover to the level of KRW 16 billion seen in the third quarter of 2026, and whether the operating loss narrows from the 2025 full-year figure of KRW 4.39 billion. The number of North American stores and any disclosure of overseas sales will also matter.

07

Valuation

PER
—
PBR
0.5×
ROE
-9.2%
EPS
-₩246
BPS
₩2,506
Dividend per share
₩0

Valuation can be read through two lenses, earnings and assets. Because controlling-shareholder net losses have accumulated over the last four quarters, the P/E ratio cannot be calculated, so earnings-based multiples are hard to compare with peers.

The price-to-book ratio, by contrast, sits near the bottom of its observed range and trades at a discount to net assets. Controlling-shareholder equity makes up all of total equity at the end of 2025, with total liabilities of KRW 15.2 billion and a debt-to-equity ratio of 18.2%.

The asset base can serve as a reference point for valuation, but the assets are currently generating little earnings while operating losses persist. No dividend yield support is currently observable.

Operating and controlling-shareholder profits were positive in 2022 and 2023, so the contrast between the earlier earnings-based comparison and today is sharp. Whether the market prices the company on its assets or on an earnings recovery will depend on the operating results of coming quarters.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-18

08

Bull factors

Signs of Slower Sales Decline

Second-quarter 2026 sales rose 1.7% quarter on quarter to KRW 18.9 billion, and the nine-month 2026 decline of 5.1% is smaller than the 10.6% full-year decline in 2025. This can be read as an early sign of channel diversification taking hold. However, third-quarter sales fell 15.5% again, so stabilization cannot yet be called firm.

Narrower Losses and a Profitable Quarter

Operating losses narrowed from KRW 1.56 billion in the third quarter of 2025 to KRW 465 million in the first quarter of 2026, and the KRW 1.16 billion loss in the third quarter of 2026 was smaller than a year earlier.

Net income attributable to controlling shareholders turned positive at KRW 215 million in the first quarter of 2026. These results support the case that losses are easing as cost structure is adjusted.

Low Debt and North American Channel Expansion

The debt-to-equity ratio was 18.2% at the end of 2025, with total liabilities of KRW 15.2 billion, which keeps financial burden relatively light. In June 2026 the company's skincare brand entered the CJ Olive Young Pasadena store, its first step into US offline retail. The balance sheet provides room to add more North American locations.

09

Bear factors

Two Straight Years of Sales Decline

Sales peaked at KRW 86 billion in 2023, then fell 4.2% to KRW 82.5 billion in 2024 and 10.6% to KRW 73.7 billion in 2025. Nine-month 2026 sales of KRW 53.5 billion were down 5.1% year on year, so the decline continues. Without a visible recovery in the top line, the shrinking scale remains the core concern.

Five Straight Quarters of Operating Losses and Renewed Net Losses

Operating losses have continued for five straight quarters, from the third quarter of 2025 through the third quarter of 2026. After the first-quarter 2026 profit, controlling-shareholder net losses returned at KRW 1.14 billion in the second quarter and KRW 1.41 billion in the third.

Pressure from Costs, Exports and Distribution

The company says raw-material cost pressure has become structural. Its Tianjin subsidiary's nine-month 2025 sales fell 33%, and US sales were nearly nil. Color cosmetics dropped 47% over the first nine months of 2025, showing weakness across product lines.

10

Risk factors

Channel Transition Risk

Shifting from a direct-sales structure to an online model has increased volatility in both sales and costs. The pace of transition spending and efficiency gains will decide near-term results. The longer the transition takes, the harder it becomes to offset declines in legacy channels.

Overseas Expansion Risk

Analysts view the North American entry as late compared with rivals already established there. Continued weakness at the China subsidiary could add pressure if demand in Greater China stays weak. With overseas sales a small share today, whether store expansion translates into revenue is the open question.

Small-Cap Liquidity and Structural Risk

As a small-cap stock, the company may see sizable trading swings and volatility. Commentary suggests that long-term competitiveness will be hard to restore if business restructuring and brand repositioning lag. The speed of shifting from the direct-sales model to online is the key variable here.

11

What to watch next

  1. Around February 2027

    Preliminary 2026 full-year results. The 2025 full-year results were disclosed on February 10, 2026. The key questions are whether sales recover above KRW 73.7 billion and whether the operating loss narrows from KRW 4.39 billion.

  2. End of March 2027

    Filing of the 2026 annual report, the next periodic report. It will confirm the full-year operating margin, controlling-shareholder net income and operating cash flow. Whether operating cash flow turns positive from KRW -1.55 billion in 2025 is a key check.

  3. Around May 15, 2027

    Filing of the first-quarter 2027 report. The comparison base is KRW 18.6 billion in sales and the KRW 215 million controlling-shareholder profit recorded in the first quarter of 2026. Whether North American store expansion shows up in revenue is also a check point.

12

Overall view

Coreana's sales peaked at KRW 86 billion in 2023 and then declined in both 2024 and 2025. The company swung to a 2025 annual operating loss of KRW 4.39 billion and a controlling-shareholder net loss of KRW 7.74 billion.

Operating losses have persisted for five straight quarters through the third quarter of 2026, and controlling-shareholder net losses have followed a single profitable quarter in the first quarter of 2026.

Still, the third-quarter 2026 operating loss of KRW 1.16 billion was narrower than a year earlier, and the 5.1% nine-month sales decline is smaller than the 10.6% full-year decline in 2025.

Balance-sheet burden is relatively light, with a debt-to-equity ratio of 18.2% and total equity of KRW 83.7 billion at the end of 2025, though operating cash flow turned negative in 2025. The bull case rests on narrower losses, financial capacity and North American channel expansion.

The bear case rests on shrinking sales, cost, export and distribution pressure, and a slow overseas turnaround. Industry exports are at record levels, yet many analysts argue Coreana is not capturing much of that benefit.

The next checkpoints are the 2026 preliminary full-year results and the 2026 annual report, where the question is whether narrower losses and a sales recovery appear together.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. vegannews.co.kr
  2. vegannews.co.kr
  3. beautynury.com
  4. cosinkorea.com
  5. m.news.nate.com
  6. thepublic.kr
  7. vegannews.co.kr
  8. huffingtonpost.kr
  9. digitaltoday.co.kr
  10. kdfnews.com
  11. jobkorea.co.kr
  12. newsworker.co.kr
  13. womentimes.co.kr
  14. m.news.nate.com
  15. wowtv.co.kr
  16. edaily.co.kr
  17. m.thebell.co.kr
  18. inews24.com

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis